Subscribe To

Price Alert Latest News Economic Calendar News

AXLA / Axcella Health stock rockets on long Covid patent win

Axcella Health Inc (NASDAQ:AXLA) saw its stock rocket some 240% higher in Tuesday's early deals after the small-cap firm announced it had secured a patent for its treatment for ‘long' Covid fatigue. The company, in a statement, said its treatment candidate AXA1125, based on compositions of ‘endogenous metabolic modulators' (otherwise referred to as EMMs) had been granted a patent from the US Patent and Trademark Office. Read More

Demo Live Account See Partner Details

Content Topics

Axcella

Health

Stock

Rockets

Long

Covid

Patent

AXLA

Posted: Aug 29 2023, 09:28

Author Name: Proactive Investors

AXLA News

By InvestorPlace
October 8, 2023

3 Pharma Stocks to Dump Before the Damage Is Done

Pharma stocks and the biotech sector can offer explosive gains. It also offers incredibly crushing defeats in which share prices decline precipitously

By InvestorPlace
September 20, 2023

Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now

The biotech sector never fails to offer up stocks full of massive issues at any given time. Developing novel therapeutic devices and pharmaceuticals i

By InvestorPlace
September 15, 2023

Why Is Axcella Health (AXLA) Stock Down 24% Today?

Axcella Health (NASDAQ: AXLA ) stock is taking a beating on Friday after the biotechnology company announced plans for a reverse stock split. Accordi

By InvestorPlace
August 31, 2023

Why Is Axcella Health (AXLA) Stock Down 21% Today?

Axcella Health (NASDAQ: AXLA ) stock is falling on Thursday following its announcement of a new Covid-19 treatment patent. However, it's not that thi

By Zacks Investment Research
August 30, 2023

Axcella (AXLA) Up on Patent Grant for Long Covid Fatigue Drug

Axcella (AXLA) shares surge 299% after the company secures a methods-of-use patent for its lead candidate, AXA1125, which is currently under developme

By InvestorPlace
August 29, 2023

Why Is Axcella Health (AXLA) Stock Up 280% Today?

A little-known penny stock is among the market's top movers today. Axcella Health (NASDAQ: AXLA ) stock surged by as much as 280% on news that it has

By Proactive Investors
August 29, 2023

Axcella Health stock rockets on long Covid patent win

Axcella Health Inc (NASDAQ:AXLA) saw its stock rocket some 240% higher in Tuesday's early deals after the small-cap firm announced it had secured a pa

By InvestorPlace
August 22, 2023

Why Is Axcella Health (AXLA) Stock Up 68% Today?

Axcella Health (NASDAQ: AXLA ) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biotechnology company. There are n

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.